Производител
Merck Sharp & Dohme B.V.
44 продукта в каталога
| Търговско име | Концентрация | Форма |
|---|---|---|
| Bridion | 100 mg/ml | инжекционен разтвор |
| Cancidas | 50 mg | прах за концентрат за инфузионен разтвор |
| CAPVAXIVE | --¹ 1 dose (0.5ml) contains: Pneumococcal polysaccharide serotype 3¹ 4 μg Pneumococcal polysaccharide serotype 6A¹ 4 μg Pneumococcal polysaccharide serotype 7F¹ 4 μg Pneumococcal polysaccharide serotype 8¹ 4 μg Pneumococcal polysaccharide serotype 9N¹ 4 μg Pneumococcal polysaccharide serotype 10A¹ 4 μg Pneumococcal polysaccharide serotype 11A¹ 4 μg Pneumococcal polysaccharide serotype 12F¹ 4 μg Pneumococcal polysaccharide serotype 15A¹ 4 μg Pneumococcal polysaccharide from deOAc15B (de-O-acetylated serotype 15B¹) 4 μg Pneumococcal polysaccharide serotype 16F¹ 4 μg Pneumococcal polysaccharide serotype 17F¹ 4 μg Pneumococcal polysaccharide serotype 19A¹ 4 μg Pneumococcal polysaccharide serotype 20A¹ 4 μg Pneumococcal polysaccharide serotype 22F¹ 4 μg Pneumococcal polysaccharide serotype 23A¹ 4 μg Pneumococcal polysaccharide serotype 23B¹ 4 μg Pneumococcal polysaccharide serotype 24F¹ 4 μg Pneumococcal polysaccharide serotype 31¹ 4 μg Pneumococcal polysaccharide serotype 33F¹ 4 μg Pneumococcal polysaccharide serotype 35B¹ 4 μg ¹Conjugated to CRM197 carrier protein. CRM197 is a nontoxic mutant of diphtheria toxin (originating from Corynebacterium diphtheriae C7) expressed recombinantly in Pseudomonas fluorescens. 1 dose (0.5 mL) contains approximately 65 μg CRM197 carrier protein. | инжекционен разтвор |
| Cubicin | 350 mg | Powder for solution for injection or infusion |
| Delstrigo | 100 mg / 300 mg / 245 mg | филмирана таблетка |
| Efficib | 50 mg / 850 mg | филмирана таблетка |
| EMEND | 80 mg | твърда капсула |
| Enflonsia | 105 mg | инжекционен разтвор |
| Ervebo | --¹ One dose (1 mL) contains: Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP¹² live, attenuated) ≥72 million pfu³ ¹Recombinant Vesicular Stomatitis Virus (rVSV) strain Indiana with a deletion of the VSV envelope glycoprotein (G) replaced with the Zaire Ebola Virus (ZEBOV) Kikwit 1995 strain surface glycoprotein (GP) ²Produced in Vero cells ³pfu= plaque-forming units | инжекционен разтвор |
| Gardasil | --¹ 1 dose (0.5 ml) contains approximately: Human Papillomavirus¹ Type 6 L1 protein², ³ 20 µg Human Papillomavirus¹ Type 11 L1 protein², ³ 40 µg Human Papillomavirus¹ Type 16 L1 protein², ³ 40 µg Human Papillomavirus¹ Type 18 L1 protein², ³ 20 µg ¹ Human Papillomavirus = HPV ² L1 protein in the form of virus-like particles produced in yeast cells (Saccharomyces cerevisiae CANADE 3C-5 (Strain 1895)) by recombinant DNA technology ³ adsorbed on amorphous aluminium hydroxyphosphate sulphate adjuvant (225 micrograms Al) | инжекционна суспензия |
| Gardasil 9 | --¹ 1 dose (0.5 ml) contains approximately: Human Papillomavirus¹ Type 6 L1 protein²,³ 30 micrograms Human Papillomavirus¹ Type 11 L1 protein²,³ 40 micrograms Human Papillomavirus¹ Type 16 L1 protein²,³ 60 micrograms Human Papillomavirus¹ Type 18 L1 protein²,³ 40 micrograms Human Papillomavirus¹ Type 31 L1 protein²,³ 20 micrograms Human Papillomavirus¹ Type 33 L1 protein²,³ 20 micrograms Human Papillomavirus¹ Type 45 L1 protein²,³ 20 micrograms Human Papillomavirus¹ Type 52 L1 protein²,³ 20 micrograms Human Papillomavirus¹ Type 58 L1 protein²,³ 20 micrograms ¹ Human Papillomavirus = HPV ² L1 protein in the form of virus-like particles produced in yeast cells (Saccharomyces cerevisiae CANADE 3C-5 (Strain 1895)) by recombinant DNA technology ³ adsorbed on amorphous aluminium hydroxyphosphate sulphate adjuvant (0.5 milligrams Al) | инжекционна суспензия |
| HBVAXPRO | 5 µg/0.5 ml | инжекционна суспензия |
| Invanz | 1 g | прах за концентрат за инфузионен разтвор |
| Isentress | 400 mg | филмирана таблетка |
| Ivemend | 150 mg | прах за инфузионен разтвор |
| Janumet | 50 mg / 850 mg | филмирана таблетка |
| Januvia | 25 mg | филмирана таблетка |
| Keytruda | 25 mg/ml | концентрат за инфузионен разтвор |
| LYFNUA | 45 mg | филмирана таблетка |
| M-M-RvaxPro | --¹ After reconstitution, one dose (0.5 ml) contains: Measles virus**¹ Enders' Edmonston strain (live, attenuated) not less than 1x10³ CCID50* Mumps virus**¹ Jeryl Lynn™ [Level B] strain (live, attenuated) not less than 12.5x10³ CCID50* Rubella virus**² Wistar RA 27/3 strain (live, attenuated) not less than 1x10³ CCID50* *50% tissue culture infectious dose **¹ Produced in chick embryo cells. **² Produced in WI-38 human diploid lung fibroblasts. | прах и разтворител за инжекционна суспензия |
| Noxafil | 40 mg/ml | перорална суспензия |
| Pifeltro | 100 mg | филмирана таблетка |
| Pneumovax 23 | solution for injection in pre-filled syringe | инжекционен разтвор в предварително напълнена спринцовка |
| PREVYMIS | 240 mg | филмирана таблетка |
| ProQuad | --¹ After reconstitution, one dose (0.5 ml) contains: Measles virus¹ Enders’ Edmonston strain (live, attenuated) not less than 3.00 log10 CCID50* Mumps virus¹ Jeryl Lynn™ (Level B) strain (live, attenuated) not less than 4.30 log10 CCID50* Rubella virus² Wistar RA 27/3 strain (live, attenuated) not less than 3.00 log10 CCID50* Varicella virus³ Oka/Merck strain (live, attenuated) not less than 3.99 log10 PFU** *50% cell culture infectious dose **plaque-forming units ¹ Produced in chick embryo cells. ² Produced in human diploid lung (WI-38) fibroblasts. ³ Produced in human diploid (MRC-5) cells. | прах и разтворител за инжекционна суспензия |
| Recarbrio | 500 mg / 500 mg / 250 mg | прах за инфузионен разтвор |
| Ristaben | 25 mg | филмирана таблетка |
| Ristfor | 50 mg / 850 mg | филмирана таблетка |
| RotaTeq | --¹ One dose (2 ml) contains: Rotavirus type* G1 not less than 2.2 x 10⁶ IU¹, ² Rotavirus type* G2 not less than 2.8 x 10⁶ IU¹, ² Rotavirus type* G3 not less than 2.2 x 10⁶ IU¹, ² Rotavirus type* G4 not less than 2.0 x 10⁶ IU¹, ² Rotavirus type* P1A[8] not less than 2.3 x 10⁶ IU¹, ² * Human-bovine rotavirus reassortants (live), produced in Vero cells. ¹ Infectious Units ² As lower confidence limit (p = 0.95) | перорален разтвор |
| Segluromet | 2.5 mg / 850 mg | филмирана таблетка |
| Sivextro | 200 mg | филмирана таблетка |
| Steglatro | 5 mg | филмирана таблетка |
| Steglujan | 5 mg / 100 mg | филмирана таблетка |
| Temodal | 20 mg | твърда капсула |
| TESAVEL | 25 mg | филмирана таблетка |
| Varivax | powder and solvent for suspension for injection in pre-filled syringe | прах и разтвор за инжекционна суспензия |
| Vaxneuvance | --¹ One dose (0.5 mL) contains: Pneumococcal polysaccharide serotype 1¹,² 2.0 µg Pneumococcal polysaccharide serotype 3¹,² 2.0 µg Pneumococcal polysaccharide serotype 4¹,² 2.0 µg Pneumococcal polysaccharide serotype 5¹,² 2.0 µg Pneumococcal polysaccharide serotype 6A¹,² 2.0 µg Pneumococcal polysaccharide serotype 6B¹,² 4.0 µg Pneumococcal polysaccharide serotype 7F¹,² 2.0 µg Pneumococcal polysaccharide serotype 9V¹,² 2.0 µg Pneumococcal polysaccharide serotype 14¹,² 2.0 µg Pneumococcal polysaccharide serotype 18C¹,² 2.0 µg Pneumococcal polysaccharide serotype 19A¹,² 2.0 µg Pneumococcal polysaccharide serotype 19F¹,² 2.0 µg Pneumococcal polysaccharide serotype 22F¹,² 2.0 µg Pneumococcal polysaccharide serotype 23F¹,² 2.0 µg Pneumococcal polysaccharide serotype 33F¹,² 2.0 µg ¹ Conjugated to CRM₁₉₇ carrier protein. CRM₁₉₇ is a nontoxic mutant of diphtheria toxin (originating from Corynebacterium diphtheriae C7) expressed recombinantly in Pseudomonas fluorescens. ² Adsorbed on aluminium phosphate adjuvant. | инжекционна суспензия |
| Velmetia | 50 mg / 850 mg | филмирана таблетка |
| Welireg | 40 mg | филмирана таблетка |
| Winrevair | 45 mg | прах и разтворител за инжекционен разтвор |
| Xelevia | 25 mg | филмирана таблетка |
| Zepatier | 50 mg / 100 mg | филмирана таблетка |
| Zerbaxa | 1 g / 0.5 g | прах за концентрат за инфузионен разтвор |
| Zinplava | 25 mg/ml | концентрат за инфузионен разтвор |